BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 4444759)

  • 21. Potentiation of the central nervous system effects of DOPA by decarboxylase inhibition: possible direct role of this neuroamino acid in brain mechanisms.
    Vazquez AJ; Sabelli HC
    Exp Neurol; 1975 Jan; 46(1):44-56. PubMed ID: 1109342
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests.
    Horst WD; Pool WR; Spiegel HE
    Eur J Pharmacol; 1973 Mar; 21(3):337-42. PubMed ID: 4736076
    [No Abstract]   [Full Text] [Related]  

  • 23. Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors.
    Lotti VJ; Porter CC
    J Pharmacol Exp Ther; 1970 Apr; 172(2):406-15. PubMed ID: 5441162
    [No Abstract]   [Full Text] [Related]  

  • 24. Biochemical and behavioral effects of l-DOPA methyl ester in cats treated with reserpine.
    Hanson LC; Utley JD
    Psychopharmacologia; 1965 Jul; 8(2):140-4. PubMed ID: 5853737
    [No Abstract]   [Full Text] [Related]  

  • 25. Potentiation of the haloperidol-induced blockade of a conditioned avoidance response by alpha-methyltyrosine.
    Monti JM; Ruiz M
    Eur J Pharmacol; 1973 Oct; 24(1):25-8. PubMed ID: 4756166
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavioral and biochemical effects of alpha-methyltyrosine in cats.
    Kitsikis A; Roberge AG
    Psychopharmacologia; 1973 Jul; 31(2):143-55. PubMed ID: 4722207
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of drugs on the behavioural and biochemical actions of intraventricular 6-hydroxydopamine.
    Taylor KM; Laverty R
    Eur J Pharmacol; 1972 Jan; 17(1):16-24. PubMed ID: 5016577
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.
    Kuruma I; Bartholini G; Tissot R; Fletscher A
    J Pharm Pharmacol; 1972 Apr; 24(4):289-94. PubMed ID: 4402836
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of alpha-methyl dopa on the reserpine-induced suppression of motor activity and the conditioned avoidance response.
    Uretsky NJ; Seiden LS
    J Pharmacol Exp Ther; 1969 Jul; 168(1):153-62. PubMed ID: 4307318
    [No Abstract]   [Full Text] [Related]  

  • 30. Antagonism by alpha-methyltyrosine of morphine induced motility in non-tolerant and tolerant rats.
    Davis WM; Babbini M; Khalsa HJ
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):267-79. PubMed ID: 5074526
    [No Abstract]   [Full Text] [Related]  

  • 31. Some actions of pentazocine on behavior and brain monoamines in the rat.
    Holtzman SG; Jewett RE
    J Pharmacol Exp Ther; 1972 May; 181(2):346-56. PubMed ID: 5030675
    [No Abstract]   [Full Text] [Related]  

  • 32. On the localization of the hypotensive effect of L-dopa.
    Henning M; Rubenson A; Trolin G
    J Pharm Pharmacol; 1972 Jun; 24(6):447-51. PubMed ID: 4403826
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of catecholamine synthesis and conditioned avoidance acquisition.
    Ahlenius S
    Pharmacol Biochem Behav; 1973; 1(3):347-50. PubMed ID: 4775861
    [No Abstract]   [Full Text] [Related]  

  • 34. The induction and antagonism of central nervous system stimulant-induced stereotyped behavior in the cat.
    Wallach MB; Gershon S
    Eur J Pharmacol; 1972 Apr; 18(1):22-6. PubMed ID: 5031271
    [No Abstract]   [Full Text] [Related]  

  • 35. 5-Hydroxytryptophan reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1973 Jan; 10(1):9-12. PubMed ID: 4540511
    [No Abstract]   [Full Text] [Related]  

  • 36. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G; Blum JE; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract]   [Full Text] [Related]  

  • 37. The effects of reserpine, alpha-methyltyrosine, and L-3,4-dihydroxyphenylalanine on brain tyrosine transaminase.
    Gibb JW; Webb JG
    Proc Natl Acad Sci U S A; 1969 Jun; 63(2):364-9. PubMed ID: 4389816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 40. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.